Etiology and Pathogenesis
The development of a valvular defect is based on damage to the valves or blood vessels. Rheumatic fever is most commonly the triggering mechanism. Less frequently, the pathology develops secondary to infective endocarditis, atherosclerosis, syphilis, or brucellosis. In recent years, there has been an increase in right-sided heart lesions among intravenous drug users, which is associated with infective endocarditis.
Dynamics of Development
The progression of a valvular defect goes through two key stages:
- Stage of compensation: the heart adapts to the workload via concentric hypertrophy of the myocardium. Circulatory disorders are mild at this stage.
- Stage of decompensation: myocardial reserves are exhausted. Hypertrophy gives way to eccentric hypertrophy with pronounced chamber dilation. This leads to blood congestion in both systemic and pulmonary circulations, anasarca, and serous cavity effusions.
Morphological Changes
In decompensated valvular disease, the gross appearance of the heart is flabby, its chambers are dilated, and thrombi are frequently found in the atrial appendages. Microscopic findings include:
- Protein and fatty dystrophy of cardiomyocytes.
- Areas of injury: myocytolysis, contraction band necrosis, and granular disintegration.
- Proliferation of connective tissue in the stroma and the presence of round-cell infiltrates.
Prognosis and Outcomes
The prognosis depends on the type of valvular defect. Mitral and aortic regurgitation (insufficiency) generally have a more favorable course, whereas aortic stenosis carries the poorest prognosis. The primary causes of mortality include cardiovascular failure, thromboembolic complications, and pneumonia.